发明名称 Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity
摘要 <p>A pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof, which is capable of treating or preventing side effects such as muscle toxicity caused by administering a statin-based lipid-lowering drug, and a pharmaceutical combination composition comprising a statin drug and a losartan drug as active ingredients are provided. The pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof provides an effect on treating or preventing muscle-related side effects caused by administration of a statin drug for treating hyperlipidemia, as well as an intrinsic pharmacological effect for treating or preventing hypertension. When administered along with a statin drug in sequence or co-administered at the same time with the statin drug, the pharmaceutical composition can exhibit an effect of effectively or significantly decreasing or preventing side effects such as muscle toxicity.</p>
申请公布号 EP2604258(A1) 申请公布日期 2013.06.19
申请号 EP20120161644 申请日期 2012.03.28
申请人 HANALL BIOPHARMA CO., LTD. 发明人 KIM, SUNG WUK;CHOE, SEONG CHOON;MIN, CHANG HEE;LEE, SOON IM;KOO, JA SEONG;SUN, SANG OUK;LEE, NA YOUNG
分类号 A61K31/00;A61K31/351;A61K31/402;A61K31/4178;A61P21/00 主分类号 A61K31/00
代理机构 代理人
主权项
地址